Detalhe da pesquisa
1.
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
Ann Hematol
; 100(10): 2529-2539, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304287
2.
Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon.
Cytotherapy
; 21(7): 699-724, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31196820
3.
Part 5: Unproven cell therapies and the commercialization of cell-based products.
Cytotherapy
; 18(1): 138-42, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719206
4.
A changing time: the International Society for Cellular Therapy embraces its industry members.
Cytotherapy
; 12(7): 853-6, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20942603
5.
Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective.
Cytotherapy
; 17(12): 1663-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26589750
6.
Cell therapy medical tourism: time for action.
Cytotherapy
; 12(8): 965-8, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21073261
7.
International seminar on the red blood cells as vehicles for drugs.
Expert Opin Biol Ther
; 12(1): 127-33, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22023703